2017
DOI: 10.1007/s11030-017-9792-1
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of novel (E)-2-(4-(1H-1,2,4-triazol-1-yl)styryl)-4- (alkyl/arylmethyleneoxy)quinazoline derivatives as antimicrobial agents

Abstract: A series of novel (E)-2-(4-(1H-1,2,4-triazol-1-yl)styryl)-4-(alkyl/arylmethyleneoxy)quinazoline derivatives (4a-4s) were synthesized in good to excellent yields, and their structures were fully characterized by [Formula: see text] NMR, [Formula: see text] NMR, HRMS and IR spectra. The structure of compound 4b was further confirmed via single-crystal X-ray diffraction analysis. The bioassay results indicated that compounds 4s, 4q and 4n inhibit phytopathogenic bacterium Xanthomonas axonopodis pv. citri (Xac) mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(12 citation statements)
references
References 43 publications
0
12
0
Order By: Relevance
“…The structure activity relationship of compound (carboxamidotriazolylbenzoic acid) substitution at position C-6 of coumarin core displayed promising activity towards A. viscosus as compared with compound 3b . The compound 3b with triazolylbenzoic acid substitute in the C-7 position exhibited highest activity towards the bacterial strains of S. aureus “Viotko”, and compound 3c with the substitution of 3-ethynylcoumarin with methyl-anthranilate exhibited remarkable antibacterial activity against the strains of S. aureus [ 31 ]. …”
Section: Main Textmentioning
confidence: 99%
“…The structure activity relationship of compound (carboxamidotriazolylbenzoic acid) substitution at position C-6 of coumarin core displayed promising activity towards A. viscosus as compared with compound 3b . The compound 3b with triazolylbenzoic acid substitute in the C-7 position exhibited highest activity towards the bacterial strains of S. aureus “Viotko”, and compound 3c with the substitution of 3-ethynylcoumarin with methyl-anthranilate exhibited remarkable antibacterial activity against the strains of S. aureus [ 31 ]. …”
Section: Main Textmentioning
confidence: 99%
“…As quinazoline and triazole are well-explored as antimicrobial agents, [98][99][100][101][102][103][104][105] Yang et al designed triazolyl-linked quinazoline hybrids. 106 As many styryl quinazolines have been reported to have anti-microbial and anti-mycobacterial activities, 107,108 hence, styryl quinazolines were considered over simple ones. Also, various alkyl (aryl) methyleneoxy units were incorporated on the quinazoline backbone in order to study its effect on the anti-microbial activity.…”
Section: Anti-tubercular Hybridsmentioning
confidence: 99%
“…Quinazolines have a broad range of pharmacological applications, in addition to their low toxicity profiles [ 3 ]. Quinazoline frameworks have great pharmacological activities as antioxidant [ 7 , 8 , 9 ], antidiabetic [ 10 , 11 , 12 ], antibacterial [ 13 , 14 , 15 ], antiviral [ 16 , 17 , 18 ], antimicrobial [ 19 , 20 , 21 ], anticancer [ 22 , 23 ], antihistaminic [ 24 , 25 , 26 ], antidiuretic [ 27 , 28 ], antitubercular [ 29 , 30 , 31 ], and anti-inflammatory [ 32 , 33 , 34 ] agents. Quinazolinones are a type of quinazoline derivative that are biologically active in the same way as quinazoline [ 35 ].…”
Section: Introductionmentioning
confidence: 99%